Thrivent Financial for Lutherans Buys 54,966 Shares of SPDR S&P Biotech ETF $XBI

Thrivent Financial for Lutherans increased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 66.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 137,863 shares of the exchange traded fund’s stock after acquiring an additional 54,966 shares during the quarter. Thrivent Financial for Lutherans’ holdings in SPDR S&P Biotech ETF were worth $16,809,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Legacy Wealth Managment LLC ID bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth approximately $32,000. Ballast Advisors LLC bought a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $36,000. Navalign LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $48,000. Barnes Dennig Private Wealth Management LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $48,000. Finally, Citizens National Bank Trust Department bought a new position in SPDR S&P Biotech ETF in the 4th quarter worth $50,000.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI stock opened at $127.67 on Tuesday. SPDR S&P Biotech ETF has a 52-week low of $78.00 and a 52-week high of $139.19. The firm has a market capitalization of $8.15 billion, a PE ratio of 11.47 and a beta of 0.85. The stock has a fifty day simple moving average of $129.46 and a two-hundred day simple moving average of $124.61.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.